These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2023618)

  • 1. Effect of calcium-channel blockers on renal function in renal-graft recipients treated with cyclosporine.
    Hauser AC; Derfler K; Stockenhuber F; Wamser P; Marosi L; Balcke P
    N Engl J Med; 1991 May; 324(21):1517. PubMed ID: 2023618
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.
    Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL
    Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study.
    van Riemsdijk IC; Mulder PG; de Fijter JW; Bruijn JA; van Hooff JP; Hoitsma AJ; Tegzess AM; Weimar W
    Transplantation; 2000 Jul; 70(1):122-6. PubMed ID: 10919587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal protective effects of calcium antagonists].
    Musialik D; Raszeja-Wanic B; Tylarski A
    Pol Merkur Lekarski; 1996 Oct; 1(4):266-70. PubMed ID: 9156942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of calcium channel blockers on cyclosporine A (Cs A) induced nephrotoxicity in rats.
    Zima T; Nĕmecek K; Hátle K; Bártová V; Stípek S
    Sb Lek; 1995; 96(1):15-21. PubMed ID: 8711361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcium channel blockers on graft outcome in cyclosporine-treated renal allograft recipients.
    Vasquez EM; Pollak R
    Transplantation; 1995 Oct; 60(8):885-7. PubMed ID: 7482755
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal actions of calcium channel antagonists.
    Osswald H; Weinheimer G; Kapp JF
    J Neural Transm Suppl; 1990; 31():39-53. PubMed ID: 2074437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium-channel blocker on tumour necrosis factor alpha (TNF alpha) production in cyclosporin-treated renal transplant recipients.
    Peces R; Urra JM
    Nephrol Dial Transplant; 1995; 10(6):871-3. PubMed ID: 7566619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does calcium channel blocker improvement of perfusion impact the functioning of kidney graft in early period after transplantation?
    Nowacki M; Droździk M; Safranow K; Kaminski M; Sulikowski T; Zietek Z; Romanowski M; Sienko J; Mizerski A; Ignaczak E; Domanski L; Pabisiak K; Bohatyrewicz R; Ostrowski M
    Transplant Proc; 2008 May; 40(4):1056-8. PubMed ID: 18555114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
    Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
    Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity.
    Rodicio JL; Morales JM; Ruilope LM
    J Hypertens Suppl; 1993 Dec; 11(6):S21-5. PubMed ID: 8169378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that calcium channel blockade prevents cyclosporine-induced exacerbation of renal ischemic injury.
    Bia MJ; Tyler K
    Transplantation; 1991 Feb; 51(2):293-5. PubMed ID: 1847248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial.
    Morales JM; Andrés A; Prieto C; Ortuño B; Estenoz J; Dorado C; Arenas J; Ruilope LM; Fernández-Cruz L; Rodicio JL
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1537-9. PubMed ID: 2652496
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cyclosporine on the rate of renal function recovery after renal transplantation.
    Dumler F
    Henry Ford Hosp Med J; 1989; 37(1):24-7. PubMed ID: 2670841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of calcium antagonists on the kidney transplant damage during prolonged cold ischemia].
    Bagirov AM
    Biull Eksp Biol Med; 1998 Apr; 125(4):465-8. PubMed ID: 9631739
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.